These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3787717)

  • 1. Drug interactions with cyclosporine: implications from animal studies.
    Whiting PH; Burke MD; Thomson AW
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):56-70. PubMed ID: 3787717
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies.
    Whiting PH; Thomson AW; Simpson JG
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):134-44. PubMed ID: 3895654
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine A: a clinical evaluation of drug interactions.
    Cockburn I
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):50-5. PubMed ID: 3787716
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications of drug therapy in the elderly.
    Morgan J; Furst DE
    Clin Rheum Dis; 1986 Apr; 12(1):227-44. PubMed ID: 3522083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug interactions of cyclosporine. Literature review].
    Bouquet S; Chapelle G; Perault MC; Rochard E; Vandel B
    Therapie; 1991; 46(2):155-62. PubMed ID: 2053094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological and clinical aspects of the interaction between non-steroidal anti-inflammatory drugs (NSAID) and diuretics.
    Koopmans PP
    Neth J Med; 1985; 28(11):524-9. PubMed ID: 3908954
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal handling and nephrotoxic effects of 3H-cyclosporine in the hen.
    Milton A; Odlind B; Dencker L
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):79-85. PubMed ID: 3787719
    [No Abstract]   [Full Text] [Related]  

  • 8. The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity.
    Gumbleton M; Brown JE; Hawksworth G; Whiting PH
    Transplantation; 1985 Oct; 40(4):454-5. PubMed ID: 4049500
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug interactions with diuretics.
    Leary WP; Reyes AJ
    S Afr Med J; 1984 Mar; 65(12):455-61. PubMed ID: 6701709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats.
    Ryffel B; Hiestand P; Foxwell B; Donatsch P; Boelsterli HJ; Maurer G; Mihatsch MJ
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):41-5. PubMed ID: 3787715
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic profiles of cyclosporine and cyclosporine G in dogs.
    Grant D; Freeman D; Keown P; Stiller C; Toman A; Blacker K
    Transplant Proc; 1987 Aug; 19(4):3494-5. PubMed ID: 3617208
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyclosporine A on the hepatic clearance rate of prednisone in isolated perfused livers of normal and uremic rats.
    Egfjord M; Daugaard H; Olgaard K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):549-52. PubMed ID: 3363654
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of therapeutic drugs on the conduct of anesthesia.
    Sweet RB
    J Ark Med Soc; 1967 Feb; 63(9):338-41. PubMed ID: 4227075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of drug interactions of cyclosporin].
    Billaud EM; Kreft-Jais C; De la Tour du Pin F; Alexandre JM
    Presse Med; 1988 Dec; 17(43):2293-5. PubMed ID: 2905455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical importance of cardiovascular drug interactions.
    Brater DC
    Prog Drug Res; 1981; 25():133-57. PubMed ID: 7031763
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
    Wood AJ; Lemaire M
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):27-32. PubMed ID: 3895666
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506.
    Burke MD; Omar G; Thomson AW; Whiting RH
    Transplantation; 1990 Nov; 50(5):901-2. PubMed ID: 1700507
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine A in contrast to a cyclosporine metabolite (OL-17) specifically inhibits growth of renal cells in culture.
    Cole E; Skorecki K; Cheung F; Wong PY; Fung LS; Levy GA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):732-7. PubMed ID: 3388511
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.